Global Monkeypox Testing Market Overview:
Global Monkeypox Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2024-2035, Considering the Base Year As 2025.
Global Monkeypox Testing Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2024-2035, with base year as 2025. This research study of Monkeypox Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Monkeypox Testing Market:
The Monkeypox Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Monkeypox Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Monkeypox Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Monkeypox Testing market has been segmented into:
PCR Testing
Serological Testing
Rapid Antigen Testing
By Application, Monkeypox Testing market has been segmented into:
Blood Samples
Swab Samples
Lesion Samples
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Monkeypox Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Monkeypox Testing market.
Top Key Players Covered in Monkeypox Testing market are:
AdvaCare
Roche
Abbott Laboratories
Becton Dickinson
Fujifilm
BioMerieux
PerkinElmer
Genomica
Hologic
QIAGEN
Siemens Healthineers
Cepheid
Nova Biomedical
Daan Gene
Thermo Fisher Scientific
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Monkeypox Testing Market Type
4.1 Monkeypox Testing Market Snapshot and Growth Engine
4.2 Monkeypox Testing Market Overview
4.3 PCR Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.3.3 PCR Testing: Geographic Segmentation Analysis
4.4 Serological Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.4.3 Serological Testing: Geographic Segmentation Analysis
4.5 Rapid Antigen Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.5.3 Rapid Antigen Testing: Geographic Segmentation Analysis
Chapter 5: Monkeypox Testing Market Application
5.1 Monkeypox Testing Market Snapshot and Growth Engine
5.2 Monkeypox Testing Market Overview
5.3 Blood Samples
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.3.3 Blood Samples: Geographic Segmentation Analysis
5.4 Swab Samples
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.4.3 Swab Samples: Geographic Segmentation Analysis
5.5 Lesion Samples
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.5.3 Lesion Samples: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Monkeypox Testing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ADVACARE
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 ROCHE
6.4 ABBOTT LABORATORIES
6.5 BECTON DICKINSON
6.6 FUJIFILM
6.7 BIOMERIEUX
6.8 PERKINELMER
6.9 GENOMICA
6.10 HOLOGIC
6.11 QIAGEN
6.12 SIEMENS HEALTHINEERS
6.13 CEPHEID
6.14 NOVA BIOMEDICAL
6.15 DAAN GENE
6.16 THERMO FISHER SCIENTIFIC
Chapter 7: Global Monkeypox Testing Market By Region
7.1 Overview
7.2. North America Monkeypox Testing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 PCR Testing
7.2.2.2 Serological Testing
7.2.2.3 Rapid Antigen Testing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Blood Samples
7.2.3.2 Swab Samples
7.2.3.3 Lesion Samples
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Monkeypox Testing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 PCR Testing
7.3.2.2 Serological Testing
7.3.2.3 Rapid Antigen Testing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Blood Samples
7.3.3.2 Swab Samples
7.3.3.3 Lesion Samples
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Monkeypox Testing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 PCR Testing
7.4.2.2 Serological Testing
7.4.2.3 Rapid Antigen Testing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Blood Samples
7.4.3.2 Swab Samples
7.4.3.3 Lesion Samples
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Monkeypox Testing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 PCR Testing
7.5.2.2 Serological Testing
7.5.2.3 Rapid Antigen Testing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Blood Samples
7.5.3.2 Swab Samples
7.5.3.3 Lesion Samples
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Monkeypox Testing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 PCR Testing
7.6.2.2 Serological Testing
7.6.2.3 Rapid Antigen Testing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Blood Samples
7.6.3.2 Swab Samples
7.6.3.3 Lesion Samples
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Monkeypox Testing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 PCR Testing
7.7.2.2 Serological Testing
7.7.2.3 Rapid Antigen Testing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Blood Samples
7.7.3.2 Swab Samples
7.7.3.3 Lesion Samples
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Monkeypox Testing Scope:
|
Report Data
|
Monkeypox Testing Market
|
|
Monkeypox Testing Market Size in 2025
|
USD XX million
|
|
Monkeypox Testing CAGR 2025 - 2032
|
XX%
|
|
Monkeypox Testing Base Year
|
2024
|
|
Monkeypox Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
AdvaCare, Roche, Abbott Laboratories, Becton Dickinson, Fujifilm, BioMerieux, PerkinElmer, Genomica, Hologic, QIAGEN, Siemens Healthineers, Cepheid, Nova Biomedical, Daan Gene, Thermo Fisher Scientific.
|
|
Key Segments
|
By Type
PCR Testing
Serological Testing
Rapid Antigen Testing
By Applications
Blood Samples
Swab Samples
Lesion Samples
|
